Loading organizations...
§ Private Profile · 5049 Edwards Ranch Rd floor 4, Fort Worth, TX 76109, USA
Cybersecurity platform securing medical devices, patient data, and IoMT assets for healthcare, with risk management, threat detection.
Based in New York, New York, Cynerio provides a subscription-based cybersecurity platform designed to protect connected medical devices, patient data, and Internet of Medical Things assets for healthcare organizations. The software-as-a-service solution delivers automated device discovery, behavior analysis, risk management, and network segmentation capabilities to defend hospital infrastructure against ransomware and data breaches without disrupting critical clinical workflows. Serving healthcare providers and enterprise hospital networks, the company's technology focuses specifically on securing operational technology and enterprise Internet of Things environments against emerging cyber threats. Cynerio has consistently earned top industry ratings from the healthcare research firm KLAS for its specialized medical device security capabilities. The business was recently acquired by the cybersecurity asset management company Axonius, marking that firm's first strategic acquisition to expand its presence in the medical sector. The healthcare cybersecurity company was originally founded in 2017.
Cynerio has raised $37.0M across 2 funding rounds.
Cynerio's technology is specifically designed to protect connected medical devices and the broader Internet of Medical Things (IoMT) within healthcare facilities, safeguarding these critical assets from cyber threats.
Cynerio provides a unique network-based platform that offers a comprehensive suite of solutions, designed to integrate and cater to the IT security needs of healthcare facilities by managing their connected device ecosystems.
The acquisition by Axonius integrated Cynerio's specialized healthcare IoT security capabilities into a broader cybersecurity portfolio, enhancing Axonius's ability to provide comprehensive asset visibility and threat management across various industries.
Cynerio's technology is specifically designed to protect connected medical devices and the broader Internet of Medical Things (IoMT) within healthcare facilities, safeguarding these critical assets from cyber threats.
Cynerio provides a unique network-based platform that offers a comprehensive suite of solutions, designed to integrate and cater to the IT security needs of healthcare facilities by managing their connected device ecosystems.
The acquisition by Axonius integrated Cynerio's specialized healthcare IoT security capabilities into a broader cybersecurity portfolio, enhancing Axonius's ability to provide comprehensive asset visibility and threat management across various industries.
Cynerio, founded in 2017, emerged as a specialized cybersecurity firm addressing the critical need for robust protection within the healthcare sector. The company's primary focus was on securing connected medical devices and the Internet of Medical Things (IoMT), which represent significant attack vectors in modern healthcare environments.
The core of Cynerio's offering was a unique network-based platform. This platform provided healthcare security leaders with the tools necessary to gain comprehensive control over the security posture of their extensive clinical engineering and IoT ecosystems. It delivered a suite of solutions designed to cater to every IT security need within healthcare facilities.
Cynerio's mission centered on empowering healthcare CISOs, enabling them to effectively manage and mitigate cyber risks associated with their connected devices. The platform offered protection against various cyber threats, ensuring the integrity and availability of essential medical equipment and patient data.
In a strategic move, Cynerio was acquired by Axonius. This acquisition integrated Cynerio's specialized expertise in healthcare IoT security into Axonius's broader cybersecurity platform. The combination aimed to provide more comprehensive asset visibility and security management across diverse organizational infrastructures, including the highly sensitive healthcare domain.
Cynerio has raised $37.0M across 2 funding rounds. Most recently, it raised $30.0M Series B in May 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 19, 2021 | $30M Series B | Dudi Klein | Accelmed, Vincent Tchenguiz, Mtip, RDC, UAE Based Investment Group | Announced |
| Jan 9, 2019 | $7M Seed | — | Accelmed, Mtip, RDC | Announced |